梅花生物：上半年净利润17.68亿元，同比增长19.96%

Group 1 - The company achieved operating revenue of 12.28 billion in the first half of 2025, representing a year-on-year decrease of 2.87% [1] - The net profit attributable to shareholders of the listed company was 1.768 billion, showing a year-on-year increase of 19.96% [1]